Common genetic variants of homocysteine metabolism in ischemic stroke: A case-control study

European Journal of Neurology

Volumn 12, Issue 8, 2005, Pages 614-618

  Linnebank, M ^a,b   Montenarh, M ^a   Kolsch H ^a   Linnebank, A ^a   Schnez, K ^a   Schweichel, D ^a   Pohl, C ^a   Urbach, H ^a   Heun, R ^a   Harbrecht, U ^a   Klockgether, T ^a   Wullner U ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Homocysteine; Hyperhomocysteinemia; Methylenetetrahydrofolate reductase; Stroke

Indexed keywords

HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVALS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VARIATION (GENETICS);

EID: 23644441339     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2005.01045.x     Document Type: Article

References (19)

1. Adams HP, Jr, Bendixen BH, Kappelle LJ et al. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35-41.
2. Faul F, Erdfelder E (1992). GPOWER: A priori, post-hoc, and compromise power analyses for MS-DOS (computer program). Department of Psychology, University of Bonn, Bonn, Germany. Free software available at: http://www. psychologie.uni-bonn.de/zentrum/download/software.htm.
3. Frosst P, Blom HJ, Milos R et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
4. Harmon DL, Shields DC, Woodside JV et al. (1999). Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17:298-309.
5. Homocysteine Studies Collaboration (2002). Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015-2022.
6. Janosikova B, Pavlikova M, Kocmanova D et al. (2003). Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease. Mol Genet Metab 79:167-175.
7. Kelly PJ, Rosand J, Kistler JP et al. (2002). Homocysteine, MTHFR 677 C > T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59:529-536.
8. Kim RJ and Becker RC (2003). Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146:948-957.
9. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG (2002). MTHFR Studies Collaboration Group: MTHFR 677 C > T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288:2023-2031.
10. Kraus JP, Janosik M, Kozich V et al. (1999). Cystathionine β-synthase mutations in homocystinuria. Hum Mutat 13:362-375.
11. Lindgren A, Brattström L, Norving B, Hultberg B, Anderson A, Johansson BB (1995). Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26:795-800.
12. Linnebank M, Hornberger A, Nowak-Göttl U, Marquardt T, Harms E, Koch HG (2000). Linkage disequilibrium of the common mutations 677 C > T and 1298 A > C of the human MTHFR gene as proven by the novel polymorphisms 129 C > T, 1068 C > T. Eur J Ped 159:472-473.
13. Linnebank M, Hornberger A, Junker R, Nowak-Goettl U, Harms E, Koch HG (2001). High prevalence of the I278T mutation of the human cystathionine β-synthase detected by a novel screening application. Thromb Haemost 85:986-988.
14. Meiklejohn DJ, Vikers MA, Dijkhuisen R, Greaves M (2001). Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 32:57-62.
15. Mudd SH, Levy HL, Kraus JP Disorders of transsulfuration (2001). In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler K, Vogelstein B, eds. McGraw-Hill, New York, NY, USA, pp. 2007-2056.
16. Pezzini A, del Zotto E, Archetti S et al. (2002). Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68 CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 33:664-669.
17. Prengler M, Sturt N, Krywawych S, Surtees R, Liesner R, Kirkham F (2001). Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinemia, CVD, and stroke in childhood. Dev Med Child Neurol 43:220-225.
18. van der Put NMJ, Gabreels F, Stevens EMB et al. (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
19. Welch GN, Loscalzo J (1998). Mechanisms of disease: homocysteine and atherosclerosis. N Engl J Med 338:1042-1050.